Evidence map›Paper›PMID 36900336›Full record

ArticleCancers2023

The Effectiveness of Fluoroscopy-Guided Manual Lymph Drainage as Part of Decongestive Lymphatic Therapy on the Superficial Lymphatic Architecture in Patients with Breast Cancer-Related Lymphoedema: A Randomised Controlled Trial.

Nele Devoogdt, Sarah Thomis, An De Groef, An-Kathleen Heroes, Ines Nevelsteen, Nick Gebruers, Wiebren A A Tjalma, Jean-Paul Belgrado, Chris Monten, Marianne Hanssens and 1 more

Full text read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nele DevoogdtDepartment of Rehabilitation Sciences, KU Leuven-University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-8117-7080
Sarah ThomisDepartment of Vascular Surgery, Centre for Lymphedema, UZ Leuven-University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-8491-6264
An De GroefDepartment of Rehabilitation Sciences, KU Leuven-University of Leuven, 3000 Leuven, Belgium.
An-Kathleen HeroesDepartment of Rehabilitation Sciences, KU Leuven-University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-3826-5464
Ines NevelsteenMultidisciplinary Breast Centre, UZ Leuven-University Hospitals Leuven, 3000 Leuven, Belgium.
Nick GebruersDepartment of Rehabilitation Sciences and Physiotherapy, University of Antwerp, MOVANT, 2610 Antwerp, Belgium.ORCID 0000-0003-4927-0434
Wiebren A A TjalmaMultidisciplinary Breast Clinic and Multidisciplinary Oedema Clinic, Antwerp University Hospital, 2650 Antwerp, Belgium.
Jean-Paul BelgradoLymphology Research Unit, Université libre de Bruxelles, 1070 Brussels, Belgium.
Chris MontenDepartment of Radiotherapy, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0003-2599-7313
Marianne HanssensDepartment of Oncology, Centre for Oncology, General Hospital Groeninge, 8500 Kortrijk, Belgium.ORCID 0009-0007-4705-8735
Tessa De VriezeDepartment of Rehabilitation Sciences, KU Leuven-University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-5719-6169

Funding

Agency for Innovation by Science and Technology IWT 60519
6 · The paper itself

Abstract

The objective of this trial was to investigate the effectiveness of fluoroscopy-guided manual lymph drainage (MLD), as part of decongestive lymphatic therapy (DLT), on the superficial lymphatic architecture in patients with chronic mild to moderate breast cancer-related lymphoedema (BCRL). This trial was a multicentre, double-blind, randomised controlled trial involving 194 participants with BCRL. Participants were randomised into (1) DLT with fluoroscopy-guided MLD (intervention group), (2) DLT with traditional MLD (control group), or (3) DLT with placebo MLD (placebo group). Superficial lymphatic architecture was evaluated as a secondary outcome, visualised by ICG lymphofluoroscopy at the baseline (B0), post-intensive (P), and post-maintenance phases (P6). Variables were (1) number of efferent superficial lymphatic vessels leaving the dermal backflow region, (2) total dermal backflow score, and (3) number of superficial lymph nodes. The traditional MLD group showed a significant decrease in the number of efferent superficial lymphatic vessels at P (

Indexed as

breast neoplasmindocyanine greenlymphatic systemlymphoedemamanual lymph drainagemolecular imagingnear infrared fluorescence lymphatic imaging

Identifiers

PMID36900336
PMCPMC10000864

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read9
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.